Akumin (TSX:AKU) Debt-to-Equity : -5.79 (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Akumin Debt-to-Equity?

Akumin's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$1,757.9 Mil. Akumin's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$286.3 Mil. Akumin's Total Stockholders Equity for the quarter that ended in Sep. 2023 was C$-353.3 Mil. Akumin's debt to equity for the quarter that ended in Sep. 2023 was -5.79.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Akumin's Debt-to-Equity or its related term are showing as below:

TSX:AKU' s Debt-to-Equity Range Over the Past 10 Years
Min: -194.95 Med: 3.36 Max: 31.63
Current: -5.79

During the past 8 years, the highest Debt-to-Equity Ratio of Akumin was 31.63. The lowest was -194.95. And the median was 3.36.

TSX:AKU's Debt-to-Equity is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.22 vs TSX:AKU: -5.79

Akumin Debt-to-Equity Historical Data

The historical data trend for Akumin's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Debt-to-Equity Chart

Akumin Annual Data

Trend

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

1.13

4.14

6.65

13.69

-30.70

Akumin Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															-194.96	-30.70	-17.83	-8.28	-5.79

Competitive Comparison of Akumin's Debt-to-Equity

For the Diagnostics & Research subindustry, Akumin's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akumin's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Akumin's Debt-to-Equity falls into.

Akumin Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Akumin's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(61.111	+	1948.948)	/	-65.48
	=	-30.70

Akumin's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1757.881	+	286.259)	/	-353.309
	=	-5.79

Akumin (TSX:AKU) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Akumin Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Akumin's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (TSX:AKU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (TSX:AKU) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

AKUMQ:USA

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Marcus Quesenberry	Senior Officer
Amy Michelle Adams	Senior Officer

Akumin (TSX:AKU) Headlines

No Headlines